Loomis, Sayles & Company’s Inogen INGN Stock Holding History
Bought
Maintained
Sold
Other funds holding INGN
BCM
NHAS
Loomis, Sayles & Company's INGN Position: Q4 2021 in Review
Loomis, Sayles & Company sold out of Inogen (INGN) in Q4 2021, closing a stake of 467,655 shares — an estimated $20.2M sold.
Loomis, Sayles & Company first reported a position in INGN in Q1 2015 and held it in 17 quarters. The position peaked at $33.6M in Q2 2021. 168 funds tracked by Wall St. Rank hold INGN as of Q4 2021.
- Loomis, Sayles & Company reported no remaining Inogen position as of Q4 2021 after selling out during the quarter.
- Loomis, Sayles & Company sold 467,655 Inogen shares in Q4 2021, an estimated $20.2M.
- Loomis, Sayles & Company first reported a position in Inogen in Q1 2015 and held it in 17 quarters.
- Loomis, Sayles & Company's Inogen position peaked at $33.6M in Q2 2021.
- 168 funds tracked by Wall St. Rank held Inogen as of Q4 2021.
Based on Loomis, Sayles & Company's 13F filing for Q4 2021, filed 14 Feb 2022.